Hansa Biopharma interim report January-March 2024
/PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and...
Source: prnewswire.com
📰 Approval Study News
Approval Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Approval Study. Real-time updates on events, politics, business and more.
Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All
In practice, patients are a little sicker and are not receiving GDMT, which is a problem, believes one HF expert.
Source: tctmd.com
S-ICD Shows Virtues, Limits in 'Real World' Postmarket Study
The subcutaneous-lead ICDs strengths and weaknesses in a registry study mirrored its performance in earlier trials, 11 years after its US approval.
North Carolina United States University Of Rochester Medical Center New York Duke University Valentina Kutyifa
Source: medscape.com